Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 10, 2016
Grant Date -
Mar 26, 2015
app pub date -
Apr 10, 2013
filing date -
Apr 12, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to a combination which comprises (a) a somatostatin analog and (b) a 11beta-hydroxylase inhibitor; each in free form or in the form of a pharmaceutical acceptable salt thereof; the use of such a combination for the preparation of a medicament for the treatment of diseases associated with increased stress hormone levels; a commercial package or product comprising such a combination; and to a method of treatment of a warm-blooded animal, especially a human.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully